Analyst upgrades:

• Oppenheimer upgraded Amdocs (NYSE: DOX) to Outperform from Perform on expectations the company is gaining momentum following recent contract wins. The firm set a $27 price target on the stock.
• FBR Capital upgraded Starwood Hotels (NYSE: HOT) to Market Perform from Underperform after raising the Lodging sector to Overweight from Neutral. The firm cites improving demand data, potential foreign exchange benefits, and continued asset sales for the upgrade and raised its target price on Starwood to $19 from $14.
• BofA/Merrill upgraded Goldman Sachs (NYSE: GS) to Buy from Neutral. The firm expects Goldman to beat Q2 estimates due favorable trading and underwriting conditions. The firm raised estimates and increased its price target to $175 from $144.
• Jefferies (NYSE: JEF) was upgraded to Neutral from Sell at Pali Capital.
• KB Home (NYSE: KBH) was upgraded to Outperform from Neutral at Credit Suisse.
• Ciena (NASDAQ: CIEN) was upgraded to Market Perform from Underperform at JMP Securities.

This post was written by Minyanville contributor Sean Udall. Sean holds position in RIMM, VMW, SUPX.

• Goldman Sachs upgraded Research in Motion (NASDAQ:RIMM)saying to buy in front of EPS. I couldn't agree more and in fact was going to say that today. Be that as it may, I doubled my RIMM long into yesterday's weakness and plan to hold into/through EPS report. My quick take is that RIMM could have one of the better reports relative to all the negative analyst actions and commentary in tech and the overall market.
  
  
• One of my themes for this upcoming EPS season is to look for stocks that have had the most negative analyst commentary coming into the quarter, as no one these days is looking at things like Price/Sales, Price/Book or Price to normalized earnings.
  
  

Analyst upgrades:

• Jefferies upgraded Abiomed (NASDAQ: ABMD) to Hold from Underperform on valuation as it believes concerns over the company's Impella heart pump are priced in at current levels. The firm lowered its target price to $7 from $8.
  
• Suntrust upgraded Somanetics (NASDAQ: SMTS) to Neutral from Reduce. The firm believes most of the risk is out of Somanetics shares and that the Q1 report could be a positive catalyst.
  
• Banc of America/Merrill upgraded shares of Telecom Italia (NYSE: TI) to Buy from Neutral on valuation and believes the company's revenue trends are improving.
• China Petroleum & Chemical (NYSE: SNP) was raised to Buy from Neutral at UBS.
• Hexcel (NYSE: HXL) and Johnson Controls (NYSE: JCI) were upgraded to Buy from Neutral at Goldman.

MOST NOTEWORTHY: OptionXpress Holdings, Supertex and Syngenta were today's noteworthy initiations:

• Merriman believes OptionXpress Holdings (NASDAQ: OXPS) has lost market share, and remains vulnerable on many fronts. They expect the competitive landscape will continue to intensify, pressuring margins and growth rates. The firm initiated shares with a Sell rating.
• Morgan Keegan started Supertex (NASDAQ: SUPX) with a Market Perform rating, citing lack of near-term catalysts.
• Syngenta (NYSE: SYT) was initiated with an Outperform rating at Bear, as they are positive on the company's defensive growth profile and valuation.

OTHER INITIATIONS:

• HSBC initiated FedEx (NYSE: FDX) with a Neutral rating and $102 target and United Parcel Service (NYSE: UPS) with an Overweight rating and $86 target.
• Credit Suisse started Liberty Media (NASDAQ: LCAPA) with an Outperform rating and $140 target.

MOST NOTEWORTHY: Sunoco, Valero Energy, UBS AG, Lehman Brothers and Supertex were today's noteworthy upgrades:

• Citigroup upgraded both Sunoco (NYSE: SUN) and Valero (NYSE: VLO) to Buy from Hold, as they believe both companies will benefit from the collapse of ethanol prices since refiners are mainly supplied under term contracts struck above current levels.
  
• Merrill upgraded shares of UBS (NYSE: UBS) to Buy from Neutral to reflect the company's lack of exposure to fixed income.
  
• Credit Suisse upgraded shares of Lehman Brothers (NYSE: LEH) to Outperform from Neutral citing improved performance prospects.
  
• Supertex (NASDAQ: SUPX) was raised to Buy from Neutral at Oppenheimer. The firm expects a rebound in all business segments, Medical is entering a seasonally strong September quarter, and notes Motorola (NYSE: MOT) shipments are growing.

OTHER UPGRADES:

• CIBC upgraded Novatel Wireless (NASDAQ: NVTL) to Sector Outperformer from Sector Performer.
  
• Suntrust upgraded American Reprographics (NYSE: ARP) to Buy from Neutral.
  
• Taiwan Semiconductor (NYSE: TSM) was upgraded to Overweight from Neutral at JP Morgan.
  
• Jefferies upgraded Dover Downs (NYSE: DDE) to Buy from Hold.